Klick Health

The FDA defines accessories

Senior Director, Social Media

Read More

The FDA released a draft guidance to clarify what constitutes a medical device accessory and how the agency intends to regulate these devices. “Medical Device Accessories: Defining Accessories and Classification Pathway for New Accessory Types” is available on the FDA website and is open for public comments 90 days from the January 20 publication date – somewhere around Sunday, April 19, so we would conservatively put the last business day for comments at Friday, April 17.

How does this affect Mobile Medical Apps?

For pharmaceutical marketers, the guidance affects only mobile medical apps that interact with a device. The underlying hardware is specifically excluded from the definition of an accessory. It says that a device will not be considered an accessory simply because it runs an app:

For example, a mobile phone that is used as a general platform for applications that include mobile medical applications that are medical devices, or an off-the-shelf computer monitor used to display medical data would not be considered accessories unless they are intended for use with such devices.

This means that your smartphone is not an accessory just because it runs a mobile medical app that has 510(k) certification. However, it leaves the door open for sensors being included in most smartwatches to be classified as medical devices. For example, the Apple Watch, soon to be released, claims to include a heart rate sensor, and both LG Electronics and Samsung have 510(k) clearances for devices:

The FDA was careful to close that door for general health apps in the other recent draft guidance: “General Wellness: Policy for Low Risk Devices.” The combination of these two guidances should allow for general fitness and weight loss use of the built in sensors without incurring the FDA’s wrath.

Types of Accessories

According to the definitions in the draft guidance there are three types of accessories:

The classification of a device follows two steps and a request from the FDA to follow its “de Novo” process to request its input. The steps are essentially:

What Does This Mean for Healthcare Marketers?

For healthcare marketers considering apps this means two things:

This draft guidance really is just a long definition of the term “accessory” and to the untrained eye it seems pretty straightforward. Readers are encouraged to talk with their regulatory groups about what this means for their mobile app plans.

You can also download the FDA Accessories Guidance POV (1.0) for internal use.

Download the Klick Health POV
More About the Author

Brad Einarsen

Brad is Klick's Senior Director leading the social practice. His group ensures that clients get the best bang for their buck on the social platforms.

More from this author

Go from news to action. Klick Wire

Weekly Digital Health Newsletter

Klick Health will NEVER spam you. Read our privacy policy

Thank you! You're now signed up to get the Klick Wire every week - news from the world of digital health marketing.

Sorry there seems to be a problem. Please try again later.